Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
SPRB Stock News and Mentions of Spruce Biosciences, Inc. Stocktwits
Updated: April 29, 2024 (10:08)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Spruce Biosciences Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Spruce Biosciences, Inc. (SPRB).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Spruce Biosciences stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Spruce Biosciences, Inc. (SPRB)
April 8, 2024 (20:31) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB - Spruce Biosciences ( NASDAQ:SPRB )
NEW YORK, April 08, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ( "Spruce" or the "Company" ) SPRB. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
In Article Trend: Neutral
March 31, 2024 (15:04) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB - Spruce Biosciences ( NASDAQ:SPRB )
NEW YORK, March 31, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ( "Spruce" or the "Company" ) SPRB. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
In Article Trend: Neutral
March 27, 2024 (16:00) / "Zacks Commentary" (by Zacks Equity Research)
Spruce Biosciences ( SPRB ) Upgraded to Buy: Here's What You Should Know
Spruce Biosciences (SPRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
In Article Trend: Somewhat-Bullish
March 26, 2024 (21:22) / "Benzinga" (by Globe Newswire)
Attention Spruce Biosciences Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 26, 2024 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Spruce Biosciences, Inc. ( "Spruce" or the "Company" ) SPRB investors that the law firm has initiated an investigation on behalf ...
In Article Trend: Neutral
March 23, 2024 (20:48) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB - Spruce Biosciences ( NASDAQ:SPRB )
NEW YORK, March 23, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc. ( "Spruce" or the "Company" ) SPRB. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
In Article Trend: Neutral
March 21, 2024 (14:20) / "Zacks Commentary" (by Zacks Equity Research)
Spruce Biosciences ( SPRB ) Falls 86% in a Month: Here's Why
Spruce Biosciences' (SPRB) CAHmelia-203 phase IIb study of tildacerfont in adult patients with CAH fails to meet the primary efficacy endpoint.
In Article Trend: Neutral
March 14, 2024 (20:15) / "Benzinga" (by Vandana Singh)
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall Spruce Biosciences' Hormonal Disorder Candidate's Future in Limbo: Analysts Downgrade Amid Tildacerfont's Trial Setback - Spruce Biosciences ( NASDAQ:SPRB )
Spruce Biosciences Inc SPRB shares plummeted on Thursday after the company released topline results from its CAHmelia-203 Phase 2b study of tildacerfont in adult classic congenital adrenal hyperplasia ( CAH ) and its CAHptain-205 study of tildacerfont in pediatric classic CAH.
In Article Trend: Somewhat-Bullish
March 14, 2024 (18:46) / "Benzinga" (by Avi Kapoor)
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views - Dick's Sporting Goods ( NYSE:DKS )
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.35% to 38,905.20 while the NASDAQ fell 0.13% to 16,156.28. The S&P 500 also fell, dropping, 0.25% to 5,152.46. Energy shares jumped by 0.8% on Thursday.
In Article Trend: Neutral
March 14, 2024 (16:14) / "Benzinga" (by Avi Kapoor)
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings - Build-A-Bear Workshop ( NYSE:BBW ) , Better Therapeutics ( NASDAQ:BTTX )
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.30% to 38,926.22 while the NASDAQ fell 0.44% to 16,107.04. The S&P 500 also fell, dropping, 0.39% to 5,145.38. Energy shares jumped by 0.4% on Thursday.
In Article Trend: Neutral
March 14, 2024 (13:46) / "Benzinga" (by Avi Kapoor)
US Stocks Higher; Producer Prices Rise 0.6% In February - Fisker ( NYSE:FSR ) , Aptorum Gr ( NASDAQ:APM )
U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.11% to 39,084.58 while the NASDAQ rose 0.30% to 16,226.13. The S&P 500 also rose, gaining, 0.14% to 5,172.33. Energy shares jumped by 0.4% on Thursday.
In Article Trend: Neutral
March 14, 2024 (13:19) / "Benzinga" (by Vandana Singh)
Why Is Spruce Biosciences Stock Plummeting On Thursday? - Spruce Biosciences ( NASDAQ:SPRB )
Wednesday, Spruce Biosciences Inc SPRB released topline results from its CAHmelia-203 Phase 2b study of tildacerfont in adult classic congenital adrenal hyperplasia ( CAH ) and its CAHptain-205 study of tildacerfont in pediatric classic CAH.
In Article Trend: Neutral
March 14, 2024 (12:05) / "Benzinga" (by Avi Kapoor)
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Robinhood Markets ( NASDAQ:HOOD )
Shares of Robinhood Markets, Inc. HOOD rose sharply in today's pre-market trading after the company reported February trading metrics. After the market close on Wednesday, Robinhood said total funded customers grew to 23.6 million at the end of February, up approximately 130,000 from January.
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website